Literature DB >> 19107345

Acute neurocognitive impairment during cranial radiation therapy in patients with intracranial tumors.

Grit Welzel1, Katharina Fleckenstein, Sabine K Mai, Brigitte Hermann, Uta Kraus-Tiefenbacher, Frederik Wenz.   

Abstract

BACKGROUND AND
PURPOSE: The objective of the current study was to evaluate the acute effects of cranial radiation therapy (CNS-RT) using different radiation doses (0, 1.8, 2, 3, >or=20 Gy) on cognitive function with special emphasis on memory. We assessed patients with and without intracranial tumors to distinguish between direct and indirect radiation effects on brain tissue.
MATERIALS AND METHODS: Eighty-two patients were evaluated with neuropsychological testing before and acutely after radiotherapy (RT). Sixty-four patients received RT to the brain (55 with, 9 without intracranial tumor). Eighteen patients treated with RT to the breast served as controls.
RESULTS: Patients with intracranial tumor demonstrated attention (19-38th percentile) and verbal memory scores (34-46th percentile) below the population average at baseline. The average Verbal Memory score was significantly different between patients with intracranial tumor and controls both at baseline (38th vs. 58th percentile) and after irradiation (27th vs. 52th percentile). Patients with preexisting peritumoral edema performed worse than patients without edema and controls. Radiation dose-related deficits were seen for working memory performance in patients with intracranial tumor.
CONCLUSION: Our data indicate no measurable impairment of cognitive functioning acutely after prophylactic cranial irradiation. Patients with intracranial tumor show a deterioration of almost all memory functions with a dose-dependent impairment in working memory. Patients with preexisting peritumoral brain edema show the strongest deterioration.

Entities:  

Mesh:

Year:  2008        PMID: 19107345     DOI: 10.1007/s00066-008-1830-6

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  43 in total

1.  Prospective evaluation of delayed central nervous system (CNS) toxicity of hyperfractionated total body irradiation (TBI).

Authors:  F Wenz; S Steinvorth; F Lohr; S Fruehauf; S Wildermuth; M van Kampen; M Wannenmacher
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-12-01       Impact factor: 7.038

2.  Intracranial meningeomas: time- and dose-dependent effects of irradiation on tumor microcirculation monitored by dynamic MR imaging.

Authors:  H Hawighorst; R Engenhart; M V Knopp; G Brix; M Grandy; M Essig; P Miltner; I Zuna; M Fuss; G van Kaick
Journal:  Magn Reson Imaging       Date:  1997       Impact factor: 2.546

3.  Stress- and treatment-induced elevations of cortisol levels associated with impaired declarative memory in healthy adults.

Authors:  C Kirschbaum; O T Wolf; M May; W Wippich; D H Hellhammer
Journal:  Life Sci       Date:  1996       Impact factor: 5.037

4.  Radiotherapeutic effects on brain function: double dissociation of memory systems.

Authors:  C L Armstrong; B W Corn; J E Ruffer; A A Pruitt; J E Mollman; P C Phillips
Journal:  Neuropsychiatry Neuropsychol Behav Neurol       Date:  2000-04

5.  Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: a Children's Cancer Group study.

Authors:  M D Ris; R Packer; J Goldwein; D Jones-Wallace; J M Boyett
Journal:  J Clin Oncol       Date:  2001-08-01       Impact factor: 44.544

6.  Ionizing radiation-induced apoptosis of proliferating stem cells in the dentate gyrus of the adult rat hippocampus.

Authors:  W Peissner; M Kocher; H Treuer; F Gillardon
Journal:  Brain Res Mol Brain Res       Date:  1999-07-23

Review 7.  Cognitive effects of chemotherapy and/or cranial irradiation in adults.

Authors:  Grit Welzel; Sarah Steinvorth; Frederik Wenz
Journal:  Strahlenther Onkol       Date:  2005-03       Impact factor: 3.621

8.  Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial.

Authors:  Christina A Meyers; Jennifer A Smith; Andrea Bezjak; Minesh P Mehta; James Liebmann; Tim Illidge; Ian Kunkler; Jean-Michel Caudrelier; Peter D Eisenberg; Jacobus Meerwaldt; Ross Siemers; Christian Carrie; Laurie E Gaspar; Walter Curran; See-Chun Phan; Richard A Miller; Markus F Renschler
Journal:  J Clin Oncol       Date:  2004-01-01       Impact factor: 44.544

9.  [Assessment of cognitive function after preventive and therapeutic whole brain irradiation using neuropsychological testing].

Authors:  Susanne Penitzka; Sarah Steinvorth; Simone Sehlleier; Martin Fuss; Michael Wannenmacher; Frederik Wenz
Journal:  Strahlenther Onkol       Date:  2002-05       Impact factor: 3.621

10.  Arrested neuronal proliferation and impaired hippocampal function following fractionated brain irradiation in the adult rat.

Authors:  T M Madsen; P E G Kristjansen; T G Bolwig; G Wörtwein
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

View more
  24 in total

1.  Shenqi fuzheng injection attenuates irradiation-induced brain injury in mice via inhibition of the NF-κB signaling pathway and microglial activation.

Authors:  Jian Zhang; Fan Tong; Qian Cai; Ling-juan Chen; Ji-hua Dong; Gang Wu; Xiao-rong Dong
Journal:  Acta Pharmacol Sin       Date:  2015-11       Impact factor: 6.150

2.  Cerebral microvascular rarefaction induced by whole brain radiation is reversible by systemic hypoxia in mice.

Authors:  Junie P Warrington; Anna Csiszar; Daniel A Johnson; Terence S Herman; Salahuddin Ahmad; Yong Woo Lee; William E Sonntag
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-12-24       Impact factor: 4.733

3.  Opposing effects of pigment epithelium-derived factor on breast cancer cell versus neuronal survival: implication for brain metastasis and metastasis-induced brain damage.

Authors:  Daniel P Fitzgerald; Preeti Subramanian; Monika Deshpande; Christian Graves; Ira Gordon; Yongzhen Qian; Yeva Snitkovsky; David J Liewehr; Seth M Steinberg; José D Paltán-Ortiz; Mary M Herman; Kevin Camphausen; Diane Palmieri; S Patricia Becerra; Patricia S Steeg
Journal:  Cancer Res       Date:  2012-01-01       Impact factor: 12.701

4.  Fractionated radiation-induced acute encephalopathy in a young rat model: cognitive dysfunction and histologic findings.

Authors:  H Zhou; Z Liu; J Liu; J Wang; D Zhou; Z Zhao; S Xiao; E Tao; W Z Suo
Journal:  AJNR Am J Neuroradiol       Date:  2011-09-15       Impact factor: 3.825

5.  A prospective study on neurocognitive effects after primary radiotherapy in high-grade glioma patients.

Authors:  Raphael Bodensohn; Stefanie Corradini; Ute Ganswindt; Jan Hofmaier; Oliver Schnell; Claus Belka; Maximilian Niyazi
Journal:  Int J Clin Oncol       Date:  2015-12-22       Impact factor: 3.402

6.  Additive effects of 5-aza-2'-deoxycytidine and irradiation on clonogenic survival of human medulloblastoma cell lines.

Authors:  Ina Patties; Jutta Jahns; Guido Hildebrandt; Rolf-Dieter Kortmann; Annegret Glasow
Journal:  Strahlenther Onkol       Date:  2009-05-15       Impact factor: 3.621

7.  An experimental study of acute radiation-induced cognitive dysfunction in a young rat model.

Authors:  Y Liu; S Xiao; J Liu; H Zhou; Z Liu; Y Xin; W Z Suo
Journal:  AJNR Am J Neuroradiol       Date:  2009-10-15       Impact factor: 3.825

8.  Cognitive Sparing during the Administration of Whole Brain Radiotherapy and Prophylactic Cranial Irradiation: Current Concepts and Approaches.

Authors:  James C Marsh; Benjamin T Gielda; Arnold M Herskovic; Ross A Abrams
Journal:  J Oncol       Date:  2010-06-27       Impact factor: 4.375

9.  Ionizing radiation promotes the acquisition of a senescence-associated secretory phenotype and impairs angiogenic capacity in cerebromicrovascular endothelial cells: role of increased DNA damage and decreased DNA repair capacity in microvascular radiosensitivity.

Authors:  Zoltan Ungvari; Andrej Podlutsky; Danuta Sosnowska; Zsuzsanna Tucsek; Peter Toth; Ferenc Deak; Tripti Gautam; Anna Csiszar; William E Sonntag
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-05-20       Impact factor: 6.053

10.  Medulloblastoma in adults. Treatment outcome, relapse patterns, and prognostic factors.

Authors:  S-F Lai; C-W Wang; Y-H Chen; K-H Lan; J C-H Cheng; A-L Cheng; S-H Kuo
Journal:  Strahlenther Onkol       Date:  2012-08-23       Impact factor: 3.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.